Zavicefta (ceftazidime/avibactam) / Pfizer, AbbVie  >>  Phase 4
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Zavicefta (ceftazidime/avibactam) / Pfizer, AbbVie
2021-006908-32: Pulmonary beta-lactam levels in ICU pneumonia Niveles intra-pulmonares de betalactámicos en neumonías en UCI

Ongoing
4
28
Europe
ceftazidima/avibactam, ceftolozano\tazobactam, EMA/369737/2020, Powder for concentrate for solution for infusion, ZAVICEFTA 2 G/0,5 G POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, Zerbaxa 1 g/0,5 g polvo para concentrado para solución para perfusión
Sonia Luque Pardos, Instituto de Salud Carlos III
Nosocomial pneumonia Neumonía nosocomial, Nosocomial pneumonia Neumonía nosocomial, Diseases [C] - Bacterial Infections and Mycoses [C01]
 
 
NCT04774094: Efficacy and Safety of Ceftazidime-Avibactam (CAZ-AVI) in Chinese Participants With HAP (Including VAP)

Completed
4
235
RoW
Zavicefta, Ceftazidime-Avibactam
Pfizer
Hospital-Acquired Pneumonia
05/23
05/23
NCT04882085: Efficacy and Safety of CAZ-AVI in the Treatment of Infections Due to Carbapenem-resistant G- Pathogens in Chinese Adults

Completed
4
60
RoW
Zavicefta, Ceftazidime-Avibactam, Best Available Treatment
Pfizer
Urinary Tract Infection, Acute Pyelonephritis, Hospital Acquired Pneumonia, Ventilator-associated Pneumonia, Bacteremia, Intra-abdominal Infection
08/23
08/23

Download Options